Futoshi Nagashima, Satoshi Inoue, Tomohiro Oda et al. Optimal chest compression for cardiac arrest until the establishment of ECPR: Secondary analysis of the SAVE-J II study. 2024 Jan 12:78:102-111. doi.

Futoshi Nagashima, Satoshi Inoue, Daisaku Matsui, Yuki Bansyoutani et al. Efficacy of damage control surgery and staged endoscopic pancreatic ductal double stenting therapy for severe pancreatic head injury: a case report. J Med Case Rep.　2021 Aug　15(1):404. doi: 10.1186/s13256-021-02995-z.

Futoshi Nagashima , Satoshi Inoue , Daisaku Matsui , Yuki Bansyoutani et al. Efficacy of damage control surgery and staged endoscopic pancreatic ductal double stenting therapy for severe pancreatic head injury: a case report. J Med Case Rep.　2021 Aug　15(1):404. doi: 10.1186/s13256-021-02995-z.

Miike T, Sakamoto Y, Narumi S, Yoshitake K, Sakurai R, Nakayama K, Inoue S. Influence of high-dose antithrombin on platelet function and blood coagulation. Acute Med Surg. 2021 May 8(1): e648. doi: 10.1002/ams2.648.

Nagashima F, Inoue S. A Feasible Operative Treatment Strategy for Trauma Patient with Difficulties in Closing the Abdomen during Open Abdomen Management (OAM) Following Damage Control Surgery-Secondary Publication. JOURNAL OF ACUTE CARE SURGERY. November 2020 10(3):83-89

Toru Miike, Yuichiro Sakamoto, Satoshi Inoue. Effect of tranexamic acid in traumatic brain injury: a case report. J Nippon Med Sch. 2020 Apr 30. doi: 10.1272/jnms.JNMS.2020_87-409.

Nagashiam F, Inoue S, Ohta M. A patient with severe polytrauma with massive pulmonary contusion and hemorrhage successfully treated with multiple treatment modalities: a case report. J Med Case Rep. 2020; 14(1):69.

Nagashima F, Inoue S, Koami H, Miike T, Sakamoto Y, Kai K. High-dose Factor XIII administration induces effective hemostasis for trauma-associated coagulopathy (TAC) both in vitro and in rat hemorrhagic shock in vivo models. J Trauma Acute Care Surg. 2018 Sep;85(3):588-597.

Onohara T, Sakamoto Y, Inoue S. Plasma Adsorption Membranes Are Able to Efficiently Remove High Mobility Group Box-1 (HMGB-1). J Nippon Med Sch. 2018;85(3):150-156.

Inoue S, Sakamoto Y, Koami H, Yamada C K, Nagashima F, Miike T, Iwamura T, Obata T. Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients with Septic Shock. J Nippon Med Sch. 2018;85(1):39-46.

Koami H, Sakamoto Y, Sakurai R, Ohta M, Imahase H, Yahata M, Umeka M, Miike T, Nagashima F, Iwamura T, Yamada KC, Inoue S. The efficacy and associated bleeding complications of recombinant antithrombin supplementation among intensive care unit patients. Thromb Res. 2017 Sep;157:84-89.

Koami H, Sakamoto Y, Miyasho T, Noguchi R, Sato N, Kai K, Chris Yamada K, Inoue S. Haptoglobin Reduces Inflammatory Cytokine INF-γ and Facilitates Clot Formation in Acute Severe Burn Rat Model. J Nippon Med Sch. 2017;84(2):64-72.

Koami H, Sakamoto Y, Sakurai R, Ohta M, Imahase H, Yahata M, Umeka M, Miike T, Nagashima F, Iwamura T, Yamada KC, Inoue S. Thromboelastometric analysis of the risk factors for return of spontaneous circulation in adult patients with out-of-hospital cardiac arrest. PLoS One. 2017 Apr 5;12(4):e0175257.

Koami H, Sakamoto Y, Yamada KC, Matsuda T, Nishi J, Nakayama K, Sakurai R, Ohta M, Imahase H, Yahata M, Umeka M, Miike T, Nagashima F, Iwamura T, Inoue S. What factor within the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) criteria is most strongly correlated with trauma induced DIC? A retrospective study using thromboelastometry in a single center in Japan. Eur J Trauma Emerg Surg. 2017 Jan 16.

Noguchi N, Inoue S, Shimanoe C, Shinchi K. Development and validation of the Humanitarian b Aid Difficulty Scale for Japanese healthcare workers. Nurs Health Sci. 2016 Dec;18(4):442-449.

Noguchi N, Inoue S, Shimanoe C, Shibayama K, Matsunaga H, Tanaka S, Ishibashi A, Shinchi K. What Kinds of Skills Are Necessary for Physicians Involved in International Disaster Response? Prehosp Disaster Med. 2016 Aug;31(4):397-406.

Noguchi N, Inoue S, Shimanoe C, Shibayama K, Shinchi K. Factors Associated with Nursing Activities in Humanitarian Aid and Disaster Relief. PLoS One. 2016 Mar 9;11(3):e0151170.

Koami H, Sakamoto Y, Sakurai R, Ohta M, Goto A, Imahase H, Yahata M, Umeka M, Miike T, Nagashima F, Iwamura T, Chris Yamada K, Inoue S. Utility of Measurement of Serum Lactate in Diagnosis of Coagulopathy Associated with Peripheral Circulatory Insufficiency: Retrospective Evaluation Using Thromboelastometry from a Single Center in Japan. J Nippon Med Sch.2016;83(4):150-7.

Koami H, Sakamoto Y, Sakurai R, Ohta M, Imahase H, Yahata M, Umeka M, Miike T, Nagashima F, Iwamura T, Yamada KC, Inoue S. The thromboelastometric discrepancy between septic and trauma induced disseminated intravascular coagulation diagnosed by the scoring system from the Japanese association for acute medicine. Medicine (Baltimore). 2016 Aug;95(31):e4514.

Miike T, Sakamoto Y, Sakurai R, Ohta M, Goto A, Imahase H, Yahata M, Umeka M, Koami H, Yamada KC, Fujita R, Nagashima F, Iwamura T, Inoue S. Effects of hyperbaric exposure on thrombus formation. Undersea Hyperb Med. 2016 May-Jun;43(3):233-8.

Koami H, Sakamoto Y, Furukawa T, Imahase H, Iwamura T, Inoue S. Utility of rotational thromboelastometry for the diagnosis of asymptomatic hyperfibrinolysis secondary to anaphylaxis. Blood Coagul Fibrinolysis. 2016 Jun;27(4):450-3

Koami H, Sakamoto Y, Ohta M, Goto A, Narumi S, Imahase H, Yahata M, Miike T, Iwamura T, Yamada KC, Inoue S. Can rotational thromboelastometry predict septic disseminated intravascular coagulation? Blood Coagul Fibrinolysis. 2015 Oct;26(7):778-83.

Yamada KC*, Inoue S*, Sakamoto Y (* equally contributed author). An Effective Support System of Emergency Medical Services With Tablet Computers. MIR mHealth uHealth 2015;3(1):e23

Patil R, Gangalum PR, Wagner S, Portilla-Arias J, Ding H, Rekechenetskiy A, Konda B, Inoue S, Black KL, Ljubimova JY, Holler E. Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer’s Disease. Macromol Biosci. 2015 Jun 2. doi: 10.1002/mabi.201500062.

Patil R, Ljubimov AV, Gangalum PR, Ding H, Portilla-Arias J, Wagner S, Inoue S, Konda B, Rekechenetskiy A, Chesnokova A, Markman JL, Ljubimov VA, Li D, Prasad RS, Black KL, Holler E, Ljubimova JY. MRI virtual biopsy and treatment of brain metastatic tumors with targeted nanobioconjugates: nanoclinic in the brain. ACS Nano. 2015 May 26;9(5):5594-608.

Sakamoto Y, Inoue S, Iwamura T, Yamashita T, Nakashima A, Koami H, Miike T, Yahata M, Imahase H, Goto A, Narumi S, Ohta M, Yamada CK. usefulness of the endotoxin activity assay to evaluate the degree of lung injury. Yonsei Med J. 2014 Jul;55(4):975-9.

Ljubimova JY, Ding H, Portilla-Arias J, Patil R, Gangalum PR, Chesnokova A, Inoue S, Rekechenetskiy A, Nassoura T, Black KL, Holler E. Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine? J Vis Exp. 2014 Jun 13;(88). doi: 10.3791/50668.

Julia Y. Ljubimova, Jose Portilla-Arias, Rameshwar Patil1, Hui Ding1, Satoshi Inoue, Janet L. Markman, Arthur Rekechenetskiy, Bindu Konda, Pallavi R. Gangalum, Alexandra Chesnokova, Alexander V. Ljubimov, Keith L. Black, Eggehard Holler. Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment. J Drug
Target. 2013 21(10):956-67

Ding H, Helguera G, Rodríguez JA, Markman J, Luria-Pérez R, Gangalum P, Portilla-Arias J, Inoue S, Daniels-Wells TR, Black K, Holler E, Penichet ML, Ljubimova JY. Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer. J Control Release. 2013 171(3):322-9

Sakamoto Y, Inoue S, Iwamura T, Yamashita T, Nakashima A, Nishimura Y, Koami H, Imahase H,Goto A, Yamada KC, Mashiko K, Yokota H. Studies on therapeutic effects and pathological features of an antithrombin preparation in septic disseminated intravascular coagulation patients. Yonsei Med J. 2013 54(3):686-9.

Ljubimova JY, Kleinman MT, Karabalin NM, Inoue S, Konda B, Gangalum P, Markman JL, Ljubimov AV, Black KL. Gene expression changes in rat brain after short and long exposures to particulate matter in Los Angeles basin air: Comparison with human brain tumors. Exp Toxicol Pathol. 2013 65(7-8):1063-71

Patil R, Portilla-Arias J, Ding H, Konda B, Rekechenetskiy A, Inoue S, Black KL., Holler E. and Ljubimova JY. Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid). Int. J. Mol. Sci. 2012, 13, 11681-11693

Ljubimova JY., Gangalum PR., Portilla-Arias J, Patil R, Konda, Paff M, Markman J, Inoue S, Espinoza A, Chesnokova A, Kleinman M, Holler E, and Black KL. Molecular Changes in Rat Brain Due to Air Nano Pollution. NSTI-Nanotech 2012 3 210-213.

S. Inoue, R. Patil, J. Portilla-Arias, H. Ding, B. Konda, A. Espinoza, D. Mongayt, J. L. Markman, A. Elramsisy, H. Westley Phillips, K.L. Black, E. Holler, J.Y. Ljubimova.Nanopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer. PLoS ONE 2012 7(2)
E31070.

S. Inoue, H. Ding, J. Portilla-Arias, J. Hu, B. Konda, M. Fujita, A. Espinoza, S. Suhane, M. Riley,M. Gates, R. Patil, M. Penichet, A.V. Ljubimov, K.L. Black, E. Holler, J.Y. Ljubimova. Polymalic
acid–based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both
HER2/neu receptor synthesis and activity. Cancer Res. 2011 71(4) (2011):1454-64.

Ding H., Inoue S., Ljubimov AV., Patil R., Portilla-Arias J., Hu J., Konda B., Wawrowsky KA., Fujita M., Karabalin N., Black KL., Holler E., and Ljubimova JY.pH-Dependent Nanobioconjugate for Systemic Inhibition of Brain Tumor Growth., Proc. Natl. Acad. Sci. USA. 2010, 107(42):18143-8.

Hu J., Ljubimova JY., Inoue S., Konda B., Patil R., Ding H., Espinoza A., Patil C., Ljubimov AV., and Black KL. Phosphodiesterase type 5 inhibitors increase trastuzumab transport and treatment efficacy in mouse metastatic brain tumor models., PLoS ONE 2010 5(4) E10108

Patil R., Portilla-Arias J., Ding H.i, Inoue S., Konda B., Hu J., Wawrowsky KA., Shin PK., Black KL., Holler E., and Ljubimova JY.,Temozolomide Delivery to Tumor Cells by a Multifunctional Nano Vehicle Based on Poly(β-L-malic acid), Pharm Res. 2010 27(11):2317-29

Lebedeva IV, Emdad L, Su ZZ, Gupta P, Sauane M, Sarkar D, Staudt MR, Liu SJ, Taher MM, Xiao R, Barral P, Lee SG, Wang D, Vozhilla N, Park ES, Chatman L, Boukerche H, Ramesh R, Inoue S, Chada S, Li R, De Pass AL, Mahasreshti PJ, Dmitriev IP, Curiel DT, Yacoub A, Grant S, Dent P, Senzer N, Nemunaitis JJ, Fisher PB.mda-7/IL-24, novel anticancer cytokine: focus onbystanderantitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Int J Oncol. 2007 31(5):985-1007.

Inoue S, Hartman A, Branch CD, Bucana CD, Stephens CL, Chada S, Ramesh R. MDA-7 in combination with bevacizumab treatment produces a synergisitic and complete inhibitory effect on lung tumor xenograft. Molecular Therapy. 2007 15(2):287-294.

Ishiyama S, Inoue S, Kobayashi K, Sano Y, Kushida N, Yamazaki Y, Yanaga K.Implantation of
rectal cancer in an anal fistula. Surg Today. 2006 36(8):747-9.

Teraishi F, Wu S, Inoue S, Zhang L, Davis JJ, Guo W, Dong F, Fang B. Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound. Prostate. 2006 66(4):430-8.

Inoue S, Shanker M, Miyahara R, Gopalan B, Patel S, Oida Y, Branch CD, Munshi A, Meyn RE, Andreeff M, Tanaka F, Mhashilkar AM, Chada S, Ramesh R. MDA-7/IL-24-Based Cancer Gene Therapy: Translation from the Laboratory to the Clinic. Current Gene Therapy. 2006 6(1):73-91.

Saito Y, Miyahara R, Gopalan B, Litvak A, Inoue S, Shanker M, Branch CD, Mhashilkar AM, Roth JA, Chada S, Ramesh R. Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene. Cancer Gene Ther. 2005 12(3):238-47.

Oida Y, Gopalan B, Miyahara R, Inoue S, Branch CD, Mhashilkar AM, Lin E, Bekele BN, Roth JA, Chada S, Ramesh R. Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Mol Cancer Ther. 2005 4(2):291-304.

Inoue S, Branch CD, Gallick GE, Chada S, Ramesh R. Inhibition of Src kinase activity by Ad-mda7 suppresses vascular endothelial growth factor expression in prostate carcinoma cells. Molecular Therapy. 2005 12(4):707-15.

Chada S, Bocangel D, Pataer A, Mhashilkar AM, Inoue S, Miyahara R, Roth JA, Grimm EA,Swisher SG, Hunt KK, Ramesh R.MDA-7/IL-24 as a Multi-Modality Therapy for Cancer. Gene Therapy for Cancer. 2007:413-433

外傷における超音波検査　外傷外科手術マニュアル 17章 医学書院 2016

外傷手術手技アトラス　Section 8 上肢　ぱーそん書房　2018

Futoshi Nagashima, Satoshi Inoue. High-dose FXIII administration is a promising treatment option for trauma-associated coagulopathy (TAC). The7th Pan-pacific Trauma Congress (2019)

Hiroyuki Koami, Yuichiro Sakamoto, Ryota Sakurai, Satoshi Inoue. Cognitive Impairment Is One of the Predictors of Long-Term Mortality of Septic Patients. The 47th Annual Congress of the SCCM (2018)

Noguchi N, Inoue S, Shimanoe C, Shibayama K, Shinchi K. Factors Associated with Nursing Activities in Humanitarian Aid and Disaster Relief. The 20th East Asian Forum of Nursing Scholars (2017)

Koami H, Sakamoto Y, Inoue S. Hyperfibrinolysis in patients with out-of-hospital cardiac arrest may contribute to poor outcome. American Heart Association (2015)

Koami H, Sakamoto Y, Inoue S. The rotational thromboelastometry (ROTEM) is an accurate measure to diagnose trauma induced disseminated intravascular coagulation. 16th European Congress of Trauma & Emergency Surgery (2015)

H Koami, Y Sakamoto, S Inoue. What factor within JAAM DIC criteria is most strongly correlated with trauma induced DIC on the subject of ROTEM findings? 9th Annual Singapore Trauma Conference (2015)

H Koami, Y Sakamoto, S Inoue. Impact of Haptoglobin on the Association Between Inflamation and Coagulation in a Rat Burn Model. 74th Annual Meeting of AAST and Clinical Congress of Acute Care Surgery (2015)

Noguchi N, Inoue S, Shinchi K. Paramedic’s activities and the necessary competencies of Japan Self-DefenseForce for International Peace Cooperation Mission. The 12th Asia PacificConference on Disaster Medicine (2015)

H Koami, Y Sakamoto, K Yamada, H Imahase, Y Nishimura,T. Yamashita, A. Nakashima, T. Iwamura, S. Inoue. A thromboelastometric evaluation of the characteristics of trauma induced coagulopathy with lower fibrinogen level: a retrospective study. 15th European Congress of Trauma & Emergency Surgery (2014)

M Yahata, Y Sakamoto, S Inoue, T Iwamura, R Fujita, H Koami, T Miike, H Imahase, S Narumi, A Goto, M Ohta. More effective use of polymyxin-B hemoperfusion for nonoperation cases. SEPSIS　(2014)

H Imahase, S Inoue, Y Sakamoto, T Miyasho ,K Yamashita. Comparison of PiCCO and VolumeView: simultaneous measurement in sepsis pig models. 34th International Symposium on Intensive Care and Emergency Medicine (2014)

Hisashi Imahase, Yuichiro Sakamoto, Taku Miyasho, Kazuto Yamashita, Jun Tamura, Takaharu Itami, Tomohito Ishizuka, Yoshio Kawamura, Tadashi Sano, Satoshi Inoue. Study of the effect of C1-esterase inhibitor administration to the sepsis pig model. Sepsis (2013)（Poster presentation）

Hiroyuki Koami, Yuichiro Sakamoto, Chris-Kosuke Yamada, Hisashi Imahase, Yoichi Nishimura,Tomoko Yamashita, Atsushi Nakashima, Takashi Iwamura, Satoshi Inoue.Analysis of the Hypothermia Induced Coagulopathy in Human Whole Blood.

Konda B, Gangalum PR., Bose D, Espinoza A, Inoue S, Black KL., Ljubimova JY.Study of brain cancer stem cell markers in association with human glioma angiogenic protein, laminin-411. 2011 World Stem Cell Summit, Pasadena, CA. (2011)

Holler E, Ding H, Portilla-Arias J, Inoue S, Patil R, Black KL, Ljubimova JY.Brain tumor treatment by a nanoconjugate containing a variety of anticancer agents. International Conference on Biomaterials Science, Tsukuba, Japan. (2011)

Ljubimova JY, Inoue S, Ding H, Portilla-Arias J, Konda B, Fujita M, Patil R, Penichet ML, Black KL, Holler E.Engineering of nanobioconjugates to treat HER2/neu positive breast cancers. International Conference on Biomaterials Science, Tsukuba, Japan. (2011)

Inoue S, Ding H, Portilla-Arias J, Patil R, Holler E, Black KL, Ljubimova JY.New generation of designed and synthesizednanobioconjugates for direct targeting and systemic treatment of her2-positive breast cancer. 17th International meeting of the European Society of Gynaecological Oncology (ESGO), Milan, Italy. (2011)

Ljubimova JY, Inoue S, Bannykh SI, Phuphanich S, Rudnick J, Ljubimov AV, Black KL.Prognostic significance of new glioma marker, laminin-411, and its inhibition in vivo by targeted nanobiopolymer. ASCO, Chicago, IL. (2011)

Holler E, Ding H, Inoue S, Portilla-Arias J, Patil R, Black KL, Ljubimova JY. Engineering nanobiopolymers based on poly(β-L-malic acid) for tumor cell drug delivery and treatment. 5th International Meeting on Developments in Materials, Processes and Applications of Emerging Technologies. Alvor, Portugal. (2011)

Ding H, Inoue S, Portilla-Arias J, Patil R, Holler , Black KL., Ljubimova JY. New nanobioconjugates against brain cancer. XX Helsinki Drug Research Congress on September 19-21, (2011)

Portilla-Arias J., Ding H., Inoue S., Patil R., Dobrovolskaia MA., McNeil SE., Patri AK., Black b KL., Holler E., Ljubimova JY.Nanobioconjugate Based on Polymalic Acid for Brain Tumor Treatment. Principal Investigators Cancer Alliance/ NCI Meeting, Boston, MA. (2011)

Inoue S, Patil R, Portilla-Arias J, Ding H, Konda B, Espinoza A, H. Phillips W, Elramsisy A, Holler E, Black KL. and Ljubimova JY. Nanoconjugate mediated inhibition of EGFR expression of triple negative breast cancer. 102st AACR Annual Meeting, (2011)

Inoue S, Ding H, Konda B, Portilla-Arias J, Patil R, Espinoza A, Rudenkyy S, Penichet ML., Riley M, Gates M, Holler E, Black KL. and LjubimovaJY. Newly designed nanobioconjugate for direct targeting and systemic treatment of HER2-positive breast cancer. 101st AACR Annual Meeting, Washington, DC. (2010), oral presentation, symposium

Ding H, Inoue S, Patil R, Portilla-Arias J, Black KL., Holler E,Dobrovolskaia MA., Clogston JD., McNeil SE., Ljubimova JY. Characterization of　Nanobioconjugates to Treat Brain and Breast Tumors. 8th Annual Multidisciplinary Scientific Symposium “Moving Targets”. University of Southern California School of Pharmacy. Los Angeles, California. (2009)

Inoue S, Penichet ML., Ding H, Helguera G, Rodriguez JA., Patil R, Holler E, Gates M, Riley MP., Black KL., Ljubimova JY.Nanobioconjugate engineering to treat HER2/neu expressing breast tumors. 2nd International Conference on Drug Discovery and Therapy, Copenhagen, Denmark: (2009)

Novel Nanobioconjugate for the Treatment of HER2/neu Expressing Tumors.AACR, Denver. Gustavo Helguera, José A. Rodríguez, Hui Ding, Satoshi Inoue, Rameshwar Patil, Eggehard Holler, Keith L. Black, Julia Y. Ljubimova, and Manuel L. Penichet (2009)

Inoue S, Ross BL, Golfeiz H, Patil R, Ding H, Rudenkyy S, Holler E, Black KL, Ljubimova JY Direct tumor targeting using nanobioconjugate with combination of monoclonal antibodies for breast cancer treatment. San Antonio Breast Cancer Meeting. San Antonio TX. (2008)

Ding H, Inoue S, Patil R, Fujita M, Khazenzon NM, Rudenkyy S, LjubimovAV,. Black KL, Holler E, Ljubimova JY. Design Of A Novel Nanoconjugate Based On Poly(b-L-Malic Acid) For Intracellular Delivery Of Anti-Tumor Agents. AACR, San Diego. Oral presentation. (2008).

Inoue S, Patil R, Fujita M, Ding H, Rudenkyy S, Khazenzon NM, Penichet ML, Eggehard Holler, Torchilin VP, Black KL, Ljubimova JY Development of a nanobioconjugate with combination of monoclonal antibodies for direct breast tumor targeting. AACR, San Diego. (2008).

Ramesh R, Inoue S and Chada S. Combined Treatment with Tarceva, an EGFR Inhibitor with Ad-mda7 Synergizes to Promote Anti-Tumor Activity Against Human Cancer Cells. Annual meeting, American Society of Gene Therapy. (2006)

Inoue S, Ramesh R. Combination treatment with Bevacizumab (Avastin) and Ad-mda7 increases antitumor activity against lung cancer. 96th Annual Meeting, American Association for Cancer Research at SanDiego, (2005).

Inoue S, Ogawa M, Yamazaki Y Clinical evaluation of the colon cancer: The number of lymphnode metastasis and the prognosis. 58th Annual Meeting, Japanese Society for Cancer of the Colon and Rectum at Saitama Japan, (2003).

Inoue S, Ogawa M, Yamazaki Y Expression of Matrix Metalloproteinase 7 and Laminin associated with Liver Metasitasis in Human Colorectal Cancer Immunohistochemical Approach. International Congress on Anti-cancer Treatment at Paris, (2002)

Inoue S, Ogawa M, Yamazaki Y. Surgical management of obstructive cancer of the left colon and rectum. World congress, international Association of Surgeons & Gastroenterologists at Crete, Greece, (2001).

Efficient Drug Delivery System Based on Polymalic Acid for Cancer Treatments.
Postdoctoral society at Cedars-Sinai Medical Center, Los Angeles California.05/09/2011

The new generation cancer treatment using nano-drug delivery system.Monthly scientific lecture at NIBEI foundation, Los Angeles California. 09/15/2012

日本と米国における外傷診療と教育の現状、医療制度の相違.　熊本外傷教育セミナー 11/8/2013

日本と米国における外傷外科診療と教育の現状. 東京都立駒込病院総合カンファレンス特別講演 9/17/2014

外傷救急医療最前線. 福岡市救急病院協会定例会特別公演　2016.3.23

佐賀大学病院における外傷外科診療の立ち上げ 〜チームビルディングの重要性〜第26回佐賀大学医学部麻酔蘇生学教室同門会総会特別公演　2016.5.7

2019年度福岡市勤務医会学術講演会　2019.10.16

大塚製薬佐賀出張所定期学術講演会　2019.12.10